Correlation Between Genmab AS and Cessatech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Cessatech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Cessatech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Cessatech AS, you can compare the effects of market volatilities on Genmab AS and Cessatech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Cessatech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Cessatech.

Diversification Opportunities for Genmab AS and Cessatech

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Genmab and Cessatech is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Cessatech AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cessatech AS and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Cessatech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cessatech AS has no effect on the direction of Genmab AS i.e., Genmab AS and Cessatech go up and down completely randomly.

Pair Corralation between Genmab AS and Cessatech

Assuming the 90 days trading horizon Genmab AS is expected to generate 0.63 times more return on investment than Cessatech. However, Genmab AS is 1.59 times less risky than Cessatech. It trades about 0.04 of its potential returns per unit of risk. Cessatech AS is currently generating about -0.04 per unit of risk. If you would invest  155,150  in Genmab AS on December 2, 2024 and sell it today you would earn a total of  5,700  from holding Genmab AS or generate 3.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  Cessatech AS

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Genmab AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Genmab AS is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Cessatech AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cessatech AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Genmab AS and Cessatech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Cessatech

The main advantage of trading using opposite Genmab AS and Cessatech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Cessatech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cessatech will offset losses from the drop in Cessatech's long position.
The idea behind Genmab AS and Cessatech AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon